https://eureka.patsnap.com/resources/blog/rd-blog/membrane-bioreactor-patent-landscape-patent-landscape/ · Patsnap · data cut-off 2026-08-31 · downloaded from the live page
Patent Landscape · Water & Environmental Technologies
Membrane bioreactor patents: who is filing, what they claim, and where the field is still open

A data-led view of the membrane bioreactor patent landscape: filing trends since 2017, technology composition across IPC classes, leading assignees and where white space remains for new claims.

9,149
Published Records
5%
Top-5 Share of All Records
-41%
Filing Growth 2021→2024
CN
Leading Jurisdiction

Filing growth = 2021 (808 records) → 2024 (474); 2024 is the last year we treat as complete. Top-5 share = the 5 largest assignees ÷ all 9,149 records in scope (CR5), not the ranked leaders only.

Check your own idea
Published byPatsnap Research··6 min readSourced from Patsnap Eureka
Overview

What the membrane bioreactor patent record actually shows

Membrane bioreactor (MBR) filings sit almost entirely inside water and wastewater treatment claim language rather than bioreactor apparatus language. Across 9,149 records published between 2015 and the 2026 cut-off, the dominant IPC subclass is C02F — water and wastewater treatment — at 96.3% of records, with B01D separation processes (filtration) the next most common at 24.6%. Classes tied to fermentation or microorganism engineering, such as C12M and C12N, each sit under 2% of records, which tells a filer that the crowded claim space is process and membrane-separation integration, not the biological apparatus itself.

China dominates the receiving-office split by a wide margin, followed at much smaller volume by the United States, the European Patent Office, WIPO's PCT route, South Korea and Australia. That distribution, combined with a long tail of single-digit filers behind a modest leader, points to a technology where the core separation mechanics are well documented but commercial deployment and regional adaptation claims remain fragmented.

Filing volume and technology composition, 2015–2026
  1. 1BL TECHNOLOGY INC106
  2. 2JIANGXI JDL ENVIRONMENTAL PROTECTION CO LTD96
  3. 3EVOQUA WATER TECHNOLOGIES LLC76
  4. 4TSINGHUA UNIVERSITY68
  5. 5ZENON TECH PARTNERSHIP66
  6. 6TONGJI UNIV66
  7. 7RES CENT FOR ECO ENVIRONMENTAL SCI THE CHINESE ACAD OF SCI65
  8. 8VEOLIA WATER SOLUTIONS & TECHNOLOGIES SUPPORT SAS64
  9. 9GENERAL ELECTRIC CO63
  10. 10NALCO CO60
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Membrane Bioreactor Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The data

Filing trend and technology composition

Publication lags filing by roughly 18 months, so the most recent one or two years in any chart will always look lower than they will eventually settle — read the tail of the trend accordingly.

Filings rose to a 2021 peak, then eased through 2024

Filings climbed from 520 in 2017 to a peak of 808 in 2021, then declined 41% to 474 by 2024 — the last year with complete publication data. Because 2025 and 2026 are still filling in, this should be read as cooling from an unusually dense filing peak, not as an early signal that interest in the technology is ending.

Filings rose to a 2021 peak, then eased through 202402505007501,000520201720182019202080820212022202320242025392026Most recent year is partial — publication lag means later filings are not yet visible.

Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.

Claims cluster in water treatment and filtration, not bioreactor hardware

C02F (water & wastewater treatment) appears in 96.3% of the 9,149 records in scope, and B01D (separation processes) in 24.6%. Every other class — bioreactor apparatus, mixing, microorganism engineering, cleaning and fermentation — sits at or below 1.8% of records, confirming that MBR patenting is overwhelmingly framed as a treatment-process problem with membrane separation as the enabling mechanism.

Claims cluster in water treatment and filtration, not bioreactor hardwareC02F · Water & wastewater treatment8,80796.3%B01D · Separation processes (filtrati…2,24824.6%C12M · Bioreactors & enzyme apparatus1641.8%B01F · Mixing & stirring991.1%C12N · Microorganisms & genetic engin…810.9%B01J · Chemical/physical processes & …650.7%B08B · Cleaning (general)490.5%C12P · Fermentation & enzymatic synth…420.5%Other7057.7%

Shares are the percentage of the 9,149 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Membrane Bioreactor Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Membrane Bioreactor Patent Landscape with Eureka

This page is one run against one query. Ask Eureka your own question about membrane bioreactor patent landscape and every answer comes back with the patent numbers behind it.

Try Eureka
Key patents

The most-cited prior art in this field

Representative filing
US20170253510A12017-09-07

US20170253510A1 — Method and system of wastewater treatment using facultative-organism-adapted membrane bioreactor

JIANGXI JDL ENVIRONMENTAL PROTECTION CO., LTD.

A wastewater treatment system built around a facultative-organism-adapted membrane bioreactor: a reaction vessel, a membrane separation system inside it, a water production system that pumps filtrate out of the membrane separation system, and an aeration system. The method aerates the reaction vessel so that dissolved oxygen concentration across more than 50% of the vessel volume stays below 1 mg/L, coupling low-oxygen biological conditioning with in-vessel membrane filtration.Filed by Jiangxi JDL Environmental Protection, 2017-09-07 — see the chat answer below for what this claim set blocks.

US20170253510A1 — patent drawing 1US20170253510A1 — patent drawing 2
View full record
Highest-citation records in scope
#Publication no.Patent titleCitations
1US7172699B1Energy efficient wastewater treatment for nitrogen and phosphorus removal204
2US6361695B1Shipboard wastewater treatment system178
3US5254253AModular shipboard membrane bioreactor system for combined wastewater streams165
4US20070209999A1Wastewater treatment system and method158
5US4885087AApparatus for mass transfer involving biological/pharmaceutical media158
6US20060201876A1Filtration apparatus comprising a membrane bioreactor and a treatment vessel for digesting organic materials155
7US6616843B1Submerged membrane bioreactor for treatment of nitrogen containing water142
8US20030201225A1Organic slurry treatment process139
9US6692642B2Organic slurry treatment process134
10US20050045557A1Method for treating wastewater in a membrane bioreactor to produce a low phosphorus effluent131

Citation counts favour older records simply because they have had longer to accumulate citations inside the searched corpus — treat them as a signal of influence on later filings, not as a ranking of current commercial relevance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Membrane Bioreactor Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis


  
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the numbers mean for a filing decision

Four figures from this dataset matter more than the rest for anyone deciding where to file or partner next.

Concentration
8.0%
of all 9,149 records

No single filer controls the field

The ranked leader holds 106 records and the top 10 assignees combined account for only 8.0% of all 9,149 records in scope. That is a genuinely fragmented field — freedom-to-operate risk is spread across many small filers rather than concentrated behind one or two blocking portfolios.

Top 10 combined = 730 records
Filing trend
-41%
2021 → 2024

A cooling peak, not a dying technology

Filings peaked at 808 in 2021 and eased to 474 by 2024, the last complete year. Given the ~18-month publication lag, 2025–2026 figures are still filling in and should not be read as continued decline.

Peak year: 2021 at 808 records
Claim framing
96.3%
of records carry C02F

This is water-treatment law, not bioreactor-apparatus law

Almost every record in scope is classified under C02F water and wastewater treatment, with B01D separation processes a distant second at 24.6%. Apparatus-focused classes like C12M bioreactors sit near 1.8%, so drafting strategy in this space should anchor on treatment-process claims first.

B01D separation processes: 24.6% of records
Geography
7,003
China-received filings

Filing activity is heavily China-weighted

China's receiving office accounts for the large majority of filings in scope, with the United States, EPO, WIPO/PCT, South Korea and Australia each receiving a much smaller share. A portfolio strategy built only around US/EP filing will miss most of the documented activity in this field.

US 490, EPO 289, WIPO 257, South Korea 195
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to membrane bioreactor patent landscape, with the prior art for and against each one.

Find the white space →
Where filers co-file
AssigneeCo-assigneeShared families
Tongji UniversityShanghai Chengtou Wastewater Treatment Co., Ltd.22
General Electric CompanyBL Technology Inc.12
General Electric CompanyWANG SIJING11
Jiangxi JDL Environmental Protection Co., Ltd.Shenzhen JDL Investment Management Co., Ltd.10
Tongji UniversityShanghai Zizheng Environmental Protection Technology Co., Ltd.9
Siemens Water TechnologiesZUBACK JOSEPH E4
Siemens Water TechnologiesSMITH GEORGE W4
Siemens Water TechnologiesJORDAN EDWARD J4

Ten co-assignee pairs are recorded in this dataset; the strongest links a university and a municipal wastewater operator, and another pairs an established water-technology multinational with a domestic partner — a pattern consistent with applied-research-to-utility deployment rather than pure corporate R&D.

Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Membrane Bioreactor Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's next

Turning this landscape into a filing decision

The numbers above tell you where the claim space is dense and where it is thin. Turning that into a defensible filing or freedom-to-operate position takes closer reading of the actual claim language.

Map claim overlap against your own draft

Run your draft claims against the densest IPC clusters — C02F and B01D — to see exactly which limitations are already occupied and which are open.

Explore claims in Eureka →

Track the fragmented leader set

With no filer above single-digit share of the field, watch for consolidation signals — acquisitions or licensing moves — among the mid-tier assignees rather than assuming the nominal leader sets the pace.

Monitor assignees in Eureka →

Read the highest-cited prior art directly

The most-cited records in this set are decades old in places; confirm which of their claims are still live before assuming they block a new filing.

Review cited patents in Eureka →
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Membrane Bioreactor Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions about membrane bioreactor patents

Answers are grounded in the same dataset. Derived from a Patsnap search on Membrane Bioreactor Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Membrane Bioreactor Patent Landscape in depth with Eureka

Go past this page: query the whole membrane bioreactor patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.